市場調查報告書
商品編碼
1416195
心臟再同步治療 (CRT) 設備市場 - 按產品(CRT-P、CRT-D)、按年齡(44 歲以下、45-64 歲、65-84 歲、85 歲以上)、最終用途和預測,2023 - 2032Cardiac Resynchronisation Therapy (CRT) Devices Market - By Product (CRT-P, CRT-D), By Age (Below 44 Years, 45- 64 Years, 65-84 Years, Above 85 Years), By End-use & Forecast, 2023 - 2032 |
在醫療技術進步、心臟衰竭盛行率增加以及患者和醫療保健專業人員意識不斷提高的推動下,全球心臟再同步治療(CRT) 設備市場預計在2023 年至2032 年期間將以5.9% 的速度成長。
根據 Radcliffe Cardiology 2023 年發表的一項研究,心臟衰竭 (HF) 是一個不斷升級的全球公共衛生問題,影響全球約 6,400 萬人。隨著人口老化比例的增加以及生活方式因素導致心臟相關問題,對先進心臟護理解決方案的需求變得更加明顯。此外,醫療保健專業人員和患者對心臟再同步治療的好處的認知不斷增強,進一步推動了行業的成長。
全球 CRT 設備市場根據產品、最終用途和地區進行分類。
在心臟同步增強、起搏和再同步雙重功能以及技術進步的推動下,CRT 起搏器市場預計將在研究期間穩步擴張。雙重功能可滿足起搏和重新同步需求,使其成為滿足心臟護理複雜需求的全面解決方案。此外,對先進心臟護理解決方案不斷成長的需求進一步推動了產品需求。
在綜合心臟護理服務和能力增強的推動下,心臟護理中心最終用途細分市場將在 2032 年之前獲得穩定成長的勢頭。心臟護理中心優先考慮個人化、以患者為中心的護理,從而提高了它們在醫療保健領域的吸引力。此外,心臟護理中心遠距醫療和遠端監測技術的整合增強了可近性並改善了患者的治療效果。
由於心血管疾病發生率不斷上升,加上中國和印度等國家醫療基礎設施不斷擴大,亞太地區心臟再同步治療設備市場預計將在 2023 年和 2032 年實現強勁成長。該地區的醫療保健行業正在經歷快速的技術進步,為該行業創造了有利的環境。此外,由於醫療保健系統專注於改善患者的治療結果,研發計劃的資金將塑造市場前景。
The global Cardiac Resynchronization Therapy (CRT) Devices Market is anticipated to expand at 5.9% during 2023-2032, driven by advancements in medical technology, increasing prevalence of heart failure, and growing awareness amongst patients & healthcare professionals.
According to a study published by Radcliffe Cardiology in 2023, Heart failure (HF) is an escalating global public health concern, affecting an estimated 64 million people worldwide. As the aging population proportion grows and lifestyle factors contribute to heart-related issues, the need for advanced cardiac care solutions becomes more pronounced. Additionally, the growing awareness among healthcare professionals and patients about the benefits of cardiac resynchronization therapy further fuels industry growth.
The global CRT devices market is classified based on product, end-use, and region.
The CRT-pacemakers segment is expected to expand at a steady pace during the study period driven by enhanced cardiac synchronization, dual functionality in pacing & resynchronization and technological advancements. The dual functionality, addressing both pacing and resynchronization needs, positions them as comprehensive solutions for the intricate demands of cardiac care. Moreover, the growing demand for advanced cardiac care solutions has further propelled product demand.
Cardiac care centers end-use segment is gaining momentum for steady growth through 2032, driven by comprehensive cardiac care services and capability enhancement. Cardiac care centers prioritize individualized, patient-centric care, boosting their appeal in the healthcare sector. Moreover, the integration of telemedicine and remote monitoring technologies in cardiac care centers enhances accessibility and improves patient outcomes.
Asia Pacific cardiac resynchronization therapy devices market is set for robust growth during 2023 and 2032, attributed to the increasing incidence of cardiovascular diseases, coupled with the expanding healthcare infrastructure in countries like China and India. The region is witnessing rapid technological advancements in the healthcare sector, creating a conducive environment for the sector. Moreover, as healthcare systems focus on improving patient outcomes, the funding for R&D initiatives will shape the market outlook.